Inflammatory bowel diseases (IBD) like Crohn's and ulcerative colitis (UC) are multifactorial
pathologies caused by environmental factors and genetic background. UC is a chronic …

The inflammatory bowel diseases (IBD) are complex immune-mediated inflammatory
diseases that are associated with significant morbidity around the world. As our …

Background: Intravenous corticosteroids are the mainstay of treatment of patients
hospitalized with acute severe ulcerative colitis (ASUC). However, 30%-40% of the patients …

Background Oral corticosteroids are first-line agents to induce remission in moderately
active ulcerative colitis [UC], but are associated with adverse effects. We compared the …

Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal
tract that encompasses two major conditions: Crohn's disease (CD) and ulcerative colitis …

The incidence and prevalence of inflammatory bowel diseases (IBDs) are rapidly increasing
worldwide. IBDs are considered an emerging problem not only in Western countries but also …

It is known that the recommended dietary allowance of selenium (Se) is dangerously close
to its tolerable upper intake level. Se is detoxified and excreted in urine as …

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by abdominal
pain, diarrhea, rectal bleeding, and weight loss. The pathogenesis and treatment of UC …

Abstract Background and Aim Azathioprine (AZA) forms the cornerstone for maintenance of
sustained remission in inflammatory bowel disease (IBD). There is apprehension regarding …

The number of patients with inflammatory bowel disease (IBD) approaching an older age,
together with the number of over-60-year-old patients newly diagnosed with IBD, is steadily …